Article Review - Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects - Internal Only - Live

This is a self-guided activity. 

Reproduced from Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects, Jason Charles Ray, Mahima Kapoor, Richard J Stark, Shuu- Jiun Wang, Lars Bendtsen, Manjit Matharu, Elspeth Jane Hutton, 92,1325-1334, 2021 with permission from BMJ Publishing Group Ltd.

License Number: 5737830871010

License Date: Feb 28, 2024

Target Audience

Physicians

Learning Objectives

By the end of this activity, learners will be able to 

  • Discuss evidence for use of CGRP antagonists
  • Summarize known and potential side effects of CCRP antagonists
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    TeleSpecialists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    TeleSpecialists designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
03/13/2024
Course expires: 
03/12/2025
Rating: 
0
Peer Reviewer(s)

Charlene Gunasekera, MD

has no relevant financial relationships to disclose at this time.
Planner(s)

Caitlyn Boyd, MHA, MSN, RN, CPHQ, CPAHA-TeleStroke

has no relevant financial relationships to disclose at this time.

Theresa Sevilis, D.O.

has a financial relationship (Stock) with Moderna;.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    TeleSpecialists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    TeleSpecialists designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please login or register to take this course.